IL161766A0 - Process for reacting alkaloids and use of the reaction products in the preparation of medicaments - Google Patents

Process for reacting alkaloids and use of the reaction products in the preparation of medicaments

Info

Publication number: IL161766A0
Authority: IL; Israel
Prior art keywords: medicaments; preparation; reaction products; alkaloids; reacting
Prior art date: 2001-11-15

Application number

IL16176602A

Other languages

English (en)

Original Assignee

Nowicky Wassili

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-11-15

Filing date

2002-10-28

Publication date

2005-11-20

2002-10-28 Application filed by Nowicky Wassili filed Critical Nowicky Wassili

2005-11-20 Publication of IL161766A0 publication Critical patent/IL161766A0/xx

Links

229930013930 alkaloid Natural products 0.000 title 1
239000007795 chemical reaction product Substances 0.000 title 1
239000003814 drug Substances 0.000 title 1
238000000034 method Methods 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07G—COMPOUNDS OF UNKNOWN CONSTITUTION
- C07G5/00—Alkaloids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/564—Three-membered rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/59—Hydrogenated pyridine rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
- C07F9/6509—Six-membered rings
- C07F9/650952—Six-membered rings having the nitrogen atoms in the positions 1 and 4
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6527—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and oxygen atoms as the only ring hetero atoms
- C07F9/6533—Six-membered rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6536—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and sulfur atoms with or without oxygen atoms, as the only ring hetero atoms
- C07F9/6539—Five-membered rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
- C07F9/6581—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms
- C07F9/6584—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms having one phosphorus atom as ring hetero atom
- C07F9/65842—Cyclic amide derivatives of acids of phosphorus, in which one nitrogen atom belongs to the ring
- C07F9/65846—Cyclic amide derivatives of acids of phosphorus, in which one nitrogen atom belongs to the ring the phosphorus atom being part of a six-membered ring which may be condensed with another ring system

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Molecular Biology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Biochemistry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Diabetes (AREA)
Physical Education & Sports Medicine (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Rheumatology (AREA)
Neurology (AREA)
Epidemiology (AREA)
Hematology (AREA)
Obesity (AREA)
Pain & Pain Management (AREA)
Immunology (AREA)
Orthopedic Medicine & Surgery (AREA)
Hospice & Palliative Care (AREA)
Pulmonology (AREA)
Psychiatry (AREA)
Emergency Medicine (AREA)
Oncology (AREA)
Dermatology (AREA)
Virology (AREA)
Endocrinology (AREA)
Communicable Diseases (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

IL16176602A 2001-11-15 2002-10-28 Process for reacting alkaloids and use of the reaction products in the preparation of medicaments IL161766A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
CH02094/01A CH695417A5 (de)	2001-11-15	2001-11-15	Verfahren zur Umsetzung von Alkaloiden.
PCT/EP2002/012003 WO2003041721A1 (fr)	2001-11-15	2002-10-28	Processus de reaction d'alcaloides et utilisation des produits de reaction dans la preparation de medicaments

Publications (1)

Publication Number	Publication Date
IL161766A0 true IL161766A0 (en)	2005-11-20

Family

ID=4567486

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
IL16176602A IL161766A0 (en)	2001-11-15	2002-10-28	Process for reacting alkaloids and use of the reaction products in the preparation of medicaments
IL161766A IL161766A (en)	2001-11-15	2004-05-04	Process for reacting alkaloids and use of the reaction products in the preparation of medicaments

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
IL161766A IL161766A (en)	2001-11-15	2004-05-04	Process for reacting alkaloids and use of the reaction products in the preparation of medicaments

Country Status (38)

Country	Link
US (1)	US20050043340A1 (fr)
EP (1)	EP1443943B1 (fr)
JP (1)	JP2005509006A (fr)
KR (1)	KR100849488B1 (fr)
CN (1)	CN100436462C (fr)
AR (1)	AR037527A1 (fr)
AT (1)	ATE485826T1 (fr)
AU (1)	AU2002346888B2 (fr)
BR (1)	BR0214173A (fr)
CA (1)	CA2465723C (fr)
CH (1)	CH695417A5 (fr)
CO (1)	CO5580784A2 (fr)
CR (1)	CR7340A (fr)
CU (1)	CU23451B7 (fr)
CY (1)	CY1111139T1 (fr)
DE (1)	DE60238134D1 (fr)
DK (1)	DK1443943T3 (fr)
EA (1)	EA007097B1 (fr)
EC (1)	ECSP045107A (fr)
ES (1)	ES2353207T3 (fr)
GE (1)	GEP20053701B (fr)
HR (1)	HRP20040430A2 (fr)
HU (1)	HU229688B1 (fr)
IL (2)	IL161766A0 (fr)
IS (1)	IS2812B (fr)
MA (1)	MA26232A1 (fr)
MX (1)	MXPA04004643A (fr)
NO (1)	NO334701B1 (fr)
NZ (1)	NZ532941A (fr)
PL (1)	PL212111B1 (fr)
PT (1)	PT1443943E (fr)
RS (1)	RS51219B (fr)
SA (1)	SA02230496B1 (fr)
TN (1)	TNSN04084A1 (fr)
TW (1)	TWI262080B (fr)
UA (1)	UA76535C2 (fr)
WO (1)	WO2003041721A1 (fr)
ZA (1)	ZA200403371B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1459753A1 (fr)	2003-03-18	2004-09-22	Nowicky, Wassyl, Dipl.-Ing. DDr.	Dérivés quaternaires de chelidonine et d'alkaloides, procédé pour leur préparation et leur utilisation dans la préparation de médicaments
WO2006053680A1 (fr) *	2004-11-19	2006-05-26	Nowicky Wassili	Procede permettant de diagnostiquer un cancer ex vivo
WO2006053649A1 (fr) *	2004-11-19	2006-05-26	Nowicky Wassili	Procede de detection du cancer
WO2007073919A2 (fr)	2005-12-28	2007-07-05	Nowicky Wassili	Procede de detection du cancer
ITMI20080284A1 (it) *	2008-02-22	2009-08-23	Indena Spa	Agenti antitumorali a struttura benzofenantridinica e formulazioni che li contengono
CA2941315C (fr) *	2016-08-12	2018-03-06	Api Labs Inc.	Pavot a teneur elevee en thebaine et procede de fabrication associe

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3865830A (en) *	1969-06-16	1975-02-11	Nikolai Mikhailovich Turkevich	Thiophosphamide derivatives of isoquinoline alkaloids, method of producing and application thereof
SU368254A1 (ru) *	1969-06-16	1973-01-26	А. И. Потопальский , В. М. Новицкий Львовский государственный медицинский институт	Способ получения соединений тиофосфамида с алкалоидами чистотела большого
AT354644B (de) *	1975-12-19	1980-01-25	Nowicky Wassili	Verfahren zur herstellung von neuen salzen von alkaloidderivaten von thiophosphorsaeure
AT377988B (de) *	1976-06-28	1985-05-28	Nowicky Wassili	Verfahren zur herstellung von neuen phosphorderivaten von alkaloiden
DE3128018A1 (de) *	1981-07-13	1983-04-07	Wassyl 1060 Wien Nowicky	"verfahren zum diagnostizieren und fuer die therapeutische behandlung von tumoren und/oder infektioesen krankheiten verschiedenster art unter praeparativem einsatz von alkaloid-verbindungen bzw. deren salze"
US4970212A (en) *	1982-05-18	1990-11-13	Nowicky Wassili	Method of treating human illnesses which compromise the ability to mount an effective immunological response
AT407608B (de) *	1994-03-18	2001-05-25	Nowicky Wassili	Mittel zur behandlung von osteoporose
AT407833B (de) *	1995-06-01	2001-06-25	Nowicky Wassyl Dr	Mittel zur behandlung von strahlenschäden
AT408719B (de) *	2000-03-22	2002-02-25	Nowicky Wassili	Mittel zur behandlung von hepatitis c

2001
- 2001-11-15 CH CH02094/01A patent/CH695417A5/de not_active IP Right Cessation
2002
- 2002-10-25 TW TW091125317A patent/TWI262080B/zh not_active IP Right Cessation
- 2002-10-28 UA UA20040604558A patent/UA76535C2/uk unknown
- 2002-10-28 US US10/495,729 patent/US20050043340A1/en not_active Abandoned
- 2002-10-28 PL PL368879A patent/PL212111B1/pl unknown
- 2002-10-28 AT AT02783017T patent/ATE485826T1/de active
- 2002-10-28 HU HU0402365A patent/HU229688B1/hu unknown
- 2002-10-28 JP JP2003543608A patent/JP2005509006A/ja active Pending
- 2002-10-28 AU AU2002346888A patent/AU2002346888B2/en not_active Ceased
- 2002-10-28 KR KR1020047007480A patent/KR100849488B1/ko not_active Expired - Fee Related
- 2002-10-28 DE DE60238134T patent/DE60238134D1/de not_active Expired - Lifetime
- 2002-10-28 GE GE8206A patent/GEP20053701B/en unknown
- 2002-10-28 IL IL16176602A patent/IL161766A0/xx unknown
- 2002-10-28 CA CA002465723A patent/CA2465723C/fr not_active Expired - Fee Related
- 2002-10-28 NZ NZ532941A patent/NZ532941A/en not_active IP Right Cessation
- 2002-10-28 MX MXPA04004643A patent/MXPA04004643A/es active IP Right Grant
- 2002-10-28 RS YUP-408/04A patent/RS51219B/sr unknown
- 2002-10-28 WO PCT/EP2002/012003 patent/WO2003041721A1/fr not_active Ceased
- 2002-10-28 EP EP02783017A patent/EP1443943B1/fr not_active Expired - Lifetime
- 2002-10-28 PT PT02783017T patent/PT1443943E/pt unknown
- 2002-10-28 EA EA200400679A patent/EA007097B1/ru not_active IP Right Cessation
- 2002-10-28 HR HR20040430A patent/HRP20040430A2/hr not_active IP Right Cessation
- 2002-10-28 BR BR0214173-6A patent/BR0214173A/pt not_active IP Right Cessation
- 2002-10-28 ES ES02783017T patent/ES2353207T3/es not_active Expired - Lifetime
- 2002-10-28 DK DK02783017.3T patent/DK1443943T3/da active
- 2002-11-15 AR ARP020104397A patent/AR037527A1/es unknown
- 2002-11-15 CN CNB021513384A patent/CN100436462C/zh not_active Expired - Fee Related
- 2002-12-30 SA SA02230496A patent/SA02230496B1/ar unknown
2004
- 2004-04-30 IS IS7245A patent/IS2812B/is unknown
- 2004-05-04 ZA ZA200403371A patent/ZA200403371B/en unknown
- 2004-05-04 IL IL161766A patent/IL161766A/en not_active IP Right Cessation
- 2004-05-05 NO NO20041845A patent/NO334701B1/no not_active IP Right Cessation
- 2004-05-11 CR CR7340A patent/CR7340A/es unknown
- 2004-05-13 TN TNP2004000084A patent/TNSN04084A1/en unknown
- 2004-05-14 EC EC2004005107A patent/ECSP045107A/es unknown
- 2004-05-14 MA MA27679A patent/MA26232A1/fr unknown
- 2004-05-17 CU CU20040105A patent/CU23451B7/es not_active IP Right Cessation
- 2004-06-01 CO CO04051024A patent/CO5580784A2/es not_active Application Discontinuation
2011
- 2011-01-24 CY CY20111100077T patent/CY1111139T1/el unknown

Also Published As

Publication number	Publication date
CA2465723A1 (fr)	2003-05-22
HRP20040430A2 (en)	2004-08-31
CR7340A (es)	2004-12-06
MA26232A1 (fr)	2004-07-01
EP1443943B1 (fr)	2010-10-27
PL212111B1 (pl)	2012-08-31
HUP0402365A2 (hu)	2005-02-28
US20050043340A1 (en)	2005-02-24
ZA200403371B (en)	2005-05-04
PT1443943E (pt)	2010-12-03
EA007097B1 (ru)	2006-06-30
NO334701B1 (no)	2014-05-12
RS40804A (sr)	2006-12-15
CN100436462C (zh)	2008-11-26
GEP20053701B (en)	2005-12-12
CA2465723C (fr)	2010-01-05
PL368879A1 (en)	2005-04-04
AU2002346888B2 (en)	2007-03-22
CH695417A5 (de)	2006-05-15
UA76535C2 (en)	2006-08-15
CY1111139T1 (el)	2015-06-11
CN1422859A (zh)	2003-06-11
AR037527A1 (es)	2004-11-17
ATE485826T1 (de)	2010-11-15
KR100849488B1 (ko)	2008-07-31
DE60238134D1 (de)	2010-12-09
DK1443943T3 (da)	2011-02-14
AU2002346888C1 (en)	2003-05-26
IS2812B (is)	2012-11-15
TNSN04084A1 (en)	2006-06-01
JP2005509006A (ja)	2005-04-07
NO20041845D0 (no)	2004-05-05
IL161766A (en)	2009-11-18
IS7245A (is)	2004-04-30
HK1054041A1 (zh)	2003-11-14
TWI262080B (en)	2006-09-21
RS51219B (sr)	2010-12-31
KR20050040859A (ko)	2005-05-03
SA02230496B1 (ar)	2008-09-10
MXPA04004643A (es)	2005-03-14
EP1443943A1 (fr)	2004-08-11
HRP20040430B1 (fr)	2012-11-30
EA200400679A1 (ru)	2004-10-28
ES2353207T3 (es)	2011-02-28
WO2003041721A1 (fr)	2003-05-22
ECSP045107A (es)	2004-06-28
NO20041845L (no)	2004-06-25
BR0214173A (pt)	2004-09-28
CO5580784A2 (es)	2005-11-30
CU23451B7 (es)	2009-10-16
HU229688B1 (en)	2014-04-28
NZ532941A (en)	2006-08-31

Publication	Publication Date	Title
HUP0102556A3 (en)	2002-12-28	Benzenesulfonamide-derivatives and their use as medicaments and process for the preparation of the compounds
HUP0104909A3 (en)	2004-11-29	2-amino-benzoxazinone derivatives for the treatment of obesity, process for their preparation and medicaments containing them
HUP0402063A3 (en)	2008-03-28	Indole-2-carboxamides process for producing them, pharmaceutical compositions containing them and use thereof
IL164851A0 (en)	2005-12-18	Process for the preparation of 7-substituted-3-quinoline and 3-quinol-4-one carbonitriles
IL153920A (en)	2010-12-30	Somatostatin analogues, processes for their production, pharmaceutical compositions comprising them and use thereof in the preparation of medicaments for therapy
HUP0401301A3 (en)	2008-03-28	Pyrrolo pyrimidines, process for their preparation, their use and pharmaceutical compositions containing them
IL203923A (en)	2013-03-24	Benzamide compounds, pharmaceutical compositions comprising them, use thereof in the preparation of medicaments and as medicaments and processes for the preparation of such compounds
CZ20011652A3 (cs)	2001-08-15	Farmaceutický přípravek zahrnující moxifloxacin, způsob výroby a použití tohoto přípravku
HUP0401250A3 (en)	2008-04-28	Medical aerosol compositions and process for their preparation
IL160797A0 (en)	2004-08-31	ORAL PHARMACEUTICAL PRODUCTS CONTAINING 17beta-ESTRADIOL-3-LOWER ALKANOATE, METHOD OF ADMINISTERING THE SAME AND PROCESS OF PREPARATION
HUP0401292A3 (en)	2011-01-28	Pyrazolo[1,5-a]pyridines, pharmaceutical compositions containing the same and process for preparation thereof
GB0112699D0 (en)	2001-07-18	Process for the preparation of prostglandins and analogues thereof
EG22992A (en)	2003-12-31	Process for the preparation of urea
IL204947A0 (en)	2010-11-30	Phenylacetamido-thiazole derivatives, process for their preparation and their use in the manufacture of medicaments, pharmaceutical compositions and kits comprising them
HUP0401987A3 (en)	2012-12-28	Derivatives of triazolyl-imidazopyridine and of the triazolylpurines useful as ligands of the adenosine a2a receptor and their use as medicaments
IL159151A0 (en)	2004-06-01	Stable polymorph of flibanserin, technical process for its preparation and the use thereof for preparing medicaments
HUP0401747A3 (en)	2005-06-28	Piridazine derivatives of hydrazono-malonitriles, their use, process for preparation of the compounds and pharmaceutical compositions containing the compounds
HUP0201785A3 (en)	2003-02-28	Dihydrobenzodiazepins, process for producing them, their use and pharmaceutical compositions containing them
PT1446107E (pt)	2014-09-12	Composições orais de libertação controlada compreendendo um composto de vitamina d e veículo ceroso
IL161766A0 (en)	2005-11-20	Process for reacting alkaloids and use of the reaction products in the preparation of medicaments
HUP0303804A3 (en)	2005-09-28	Ligands of the avss6 integrin, process for their preparation, their use and pharmaceutical compositions containing them
GB0128680D0 (en)	2002-01-23	Hybrid glycosylated products and their production and use
GB9909592D0 (en)	1999-06-23	Process for the preparation of calanolide precursors
EG22846A (en)	2003-09-30	Process for the preparation of urea
IL170505A (en)	2013-04-30	A process for creating, reacting and using alkaloid reaction products